Deletion of CEACAM1 does not affect retinal and choroidal morphology or transcriptome
Cell and Tissue Research · 2026-07 · 405 (1)
DOI: 10.1007/s00441-026-04087-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell and Tissue Research, online erschienen am 26.06.2026. Verfasst von Laura Hannig und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroanatomy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Choroid, Retina, CEACAM1 Protein, Transcriptome. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmut Ecker Stiftung, Universitätsklinikum Hamburg-Eppendorf (UKE).
Abstract (Originalsprache)
CEACAM1 (CC1) is an important mediator of cell proliferation and adhesion and serves as an angiogenic factor through interaction with VEGF. Although the role of CC1 has been extensively studied in organs such as the heart, liver and lung in which CC1 is considered an important regulator of various pathological conditions, little is known about the function of CEACAM1 in the eye. In this study, we investigated the expression and function of CC1 in the retina and choroid of healthy adult mice using immunohistochemistry, fluorescence activated cell sorting (FACS) and RNA sequencing. We found CC1 to be expressed in endothelial and myeloid cells of the retina and the choroid. However, deletion of CC1 did not result in vascular abnormalities of the retina and choroid or changes in retinal myeloid cell morphology and number. Furthermore, the retinal architecture was not affected and morphometric measurements of the thickness of the inner and outer retinal layers were not altered by deletion of CC1. Accordingly, we did not observe structural or transcriptomic changes in the choroid. Our data suggest that the role of CC1 in the adult eye during steady state is attenuated or can be compensated by other molecular mediators. However, one could speculate that CC1 may become functionally relevant during pathological conditions, such as in neovascular eye diseases like proliferative diabetic retinopathy or neovascular age-related macular degeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Neuroanatomy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Ophthalmology, Universitaetsklinikum Würzburg, Würzburg, Germany.
- Institute of Anatomy and Cell Biology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
- Institute for Molecular Neurogenetics, Center for Molecular Neurobiology Hamburg, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Neuroanatomy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. a.schlecht@uke.de.
ORCID-Profile: Anja Schlecht
Förderung
- Helmut Ecker Stiftung
- Universitätsklinikum Hamburg-Eppendorf (UKE)
Zitieren
APA
Hannig, L., Braunger, B. M., Kleefeldt, N., Cagol, L., Zimmermann, J., Brunne, B., Ahmad, H., Vallon, M., Ergün, S., Hillenkamp, J., Neueder, A., & Schlecht, A. (2026). Deletion of CEACAM1 does not affect retinal and choroidal morphology or transcriptome. Cell and Tissue Research, 405(1). https://doi.org/10.1007/s00441-026-04087-0
Vancouver
Hannig L, Braunger BM, Kleefeldt N, Cagol L, Zimmermann J, Brunne B, et al. Deletion of CEACAM1 does not affect retinal and choroidal morphology or transcriptome. Cell and Tissue Research. 2026;405(1). doi:10.1007/s00441-026-04087-0
BibTeX
@article{Hannig2026,
author = {Hannig, Laura and Braunger, Barbara M and Kleefeldt, Nikolai and Cagol, Lea and Zimmermann, Jonathan and Brunne, Bianka and Ahmad, Hamza and Vallon, Mario and Ergün, Süleyman and Hillenkamp, Jost and Neueder, Andreas and Schlecht, Anja},
title = {Deletion of CEACAM1 does not affect retinal and choroidal morphology or transcriptome},
journal = {Cell and Tissue Research},
year = {2026},
volume = {405},
number = {1},
doi = {10.1007/s00441-026-04087-0}
}
EUVIMED